PAVmed financials
$3.82+0.53%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.0K | $3.0M | $2.5M | $377.0K | $500.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | -$147.0K | -$1.8M | -$4.0M | -$3.2M | -$85.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | −207.0% | −61.6% | −161.8% | −858.6% | −17.0% | — | — | — | — | — |
| Operating income | -$21.8M | -$44.5M | -$68.8M | -$91.1M | -$54.4M | -$23.4M | -$14.3M | -$10.6M | -$8.0M | -$5.7M |
| Net income | -$3.8M | $32.0M | -$66.3M | -$89.3M | -$50.6M | -$34.6M | -$16.7M | -$18.8M | -$10.4M | -$5.7M |
| Net margin | −5315.5% | 1067.3% | −2702.7% | −23677.5% | −10126.0% | — | — | — | — | — |
| Diluted EPS | $-5.63 | $14.90 | $-274.80 | $-450.90 | $-292.50 | $-328.50 | $-247.50 | $-378.00 | $-346.50 | $-198.00 |
| EBITDA | -$21.7M | -$43.3M | -$65.9M | -$88.6M | -$54.2M | -$23.3M | -$14.3M | -$10.6M | -$8.0M | -$5.6M |
| Operating cash flow | -$5.2M | -$33.6M | -$52.0M | -$71.0M | -$40.6M | -$21.9M | -$13.4M | -$8.8M | -$6.6M | -$4.5M |
| Free cash flow | -$5.2M | -$33.6M | -$52.3M | -$72.5M | -$42.1M | -$22.0M | -$13.4M | -$8.8M | -$6.6M | -$4.5M |
| Diluted shares | 0.7M | 2.2M | 0.2M | 0.2M | 0.2M | 0.1M | 0.1M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.5M | $1.2M | $19.6M | $39.7M | $77.3M | $17.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $11.1M | $29.1M | $44.2M | $33.6M | $0.00 | $15.0M |
| Total assets | $38.8M | $30.7M | $33.1M | $54.0M | $87.0M | $19.8M |
| Total liabilities | $16.5M | $37.7M | $57.1M | $43.0M | $7.6M | $20.3M |
| Shareholders' equity | $22.3M | -$7.0M | -$24.0M | $10.9M | $79.4M | -$473.0K |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology